Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study

2019 ◽  
Vol 71 (6) ◽  
pp. 892-900 ◽  
Author(s):  
Rishi J. Desai ◽  
Ajinkya Pawar ◽  
Michael E. Weinblatt ◽  
Seoyoung C. Kim
Sign in / Sign up

Export Citation Format

Share Document